Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody - Meneses-Lorente, G; Friess, T; Kolm, I (Cancer Chemother Pharmacol, 2015)